|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q55168695
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000206.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q55168695
|
|
024
|
|
|
‡a
0000-0002-0138-0944
‡2
orcid
|
|
024
|
|
|
‡a
9238568800
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q55168695
|
|
100
|
0 |
|
‡a
Helena Rebelo-de-Andrade
‡9
ast
‡9
es
‡9
sl
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Helena Rebelo-de-Andrade
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Helena Rebelo-de-Andrade
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Antibody response to the influenza vaccine in healthcare workers
|
|
670
|
|
|
‡a
Author's Bronchiolitis caused by respiratory syncytial virus in an area of portugal: epidemiology, clinical features, and risk factors
|
|
670
|
|
|
‡a
Author's Characterization of influenza A/Fu gian /411/2002
|
|
670
|
|
|
‡a
Author's Characterization of influenza A/Fu gian /411/2002(H3N2)-like viruses isolated in Portugal between 2003 and 2005.
|
|
670
|
|
|
‡a
Author's Different diagnostic methods for detection of influenza epidemics
|
|
670
|
|
|
‡a
Author's Distinct kinetics and pathways of apoptosis in influenza A and B virus infection.
|
|
670
|
|
|
‡a
Author's Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004.
|
|
670
|
|
|
‡a
Author's Genetic evolution of PB1 in the zoonotic transmission of influenza A
|
|
670
|
|
|
‡a
Author's Genetic evolution of PB1 in the zoonotic transmission of influenza A(H1) virus.
|
|
670
|
|
|
‡a
Author's Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.
|
|
670
|
|
|
‡a
Author's Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.
|
|
670
|
|
|
‡a
Author's Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.
|
|
670
|
|
|
‡a
Author's Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
|
|
670
|
|
|
‡a
Author's Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
|
|
670
|
|
|
‡a
Author's Heterogeneous Selective Pressure Acting on Influenza B Victoria- and Yamagata-Like Hemagglutinins
|
|
670
|
|
|
‡a
Author's Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
|
|
670
|
|
|
‡a
Author's Influenza activity 2000/2001
|
|
670
|
|
|
‡a
Author's Molecular characterization of the HA gene of influenza type B viruses
|
|
670
|
|
|
‡a
Author's Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain
|
|
670
|
|
|
‡a
Author's Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity
|
|
670
|
|
|
‡a
Author's Reverse genetics vaccine seeds for influenza: Proof of concept in the source of PB1 as a determinant factor in virus growth and antigen yield
|
|
670
|
|
|
‡a
Author's Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection
|
|
909
|
|
|
‡a
(orcid) 0000000201380944
‡9
1
|
|
909
|
|
|
‡a
(scopus) 9238568800
‡9
1
|
|
919
|
|
|
‡a
characterizationofinfluenzaafu gian 411
‡A
Characterization of influenza A/Fu gian /411/2002
‡9
1
|
|
919
|
|
|
‡a
characterizationofinfluenzaafu gian 4112002h3n2likevirusesisolatedinportugalbetween2003and
‡A
Characterization of influenza A/Fu gian /411/2002(H3N2)-like viruses isolated in Portugal between 2003 and 2005.
‡9
1
|
|
919
|
|
|
‡a
differentdiagnosticmethodsfordetectionofinfluenzaepidemics
‡A
Different diagnostic methods for detection of influenza epidemics
‡9
1
|
|
919
|
|
|
‡a
distinctkineticsandpathwaysofapoptosisininfluenzaaandbvirusinfection
‡A
Distinct kinetics and pathways of apoptosis in influenza A and B virus infection.
‡9
1
|
|
919
|
|
|
‡a
excessmortalityassociatedwithinfluenzaepidemicsinportugal1980to
‡A
Excess mortality associated with influenza epidemics in Portugal, 1980 to 2004.
‡9
1
|
|
919
|
|
|
‡a
geneticevolutionofpb1inthezoonotictransmissionofinfluenzaa
‡A
Genetic evolution of PB1 in the zoonotic transmission of influenza A
‡9
1
|
|
919
|
|
|
‡a
geneticevolutionofpb1inthezoonotictransmissionofinfluenzaah1virus
‡A
Genetic evolution of PB1 in the zoonotic transmission of influenza A(H1) virus.
‡9
1
|
|
919
|
|
|
‡a
genomicsignaturesandantiviraldrugsusceptibilityprofileofah1n1pdm09
‡A
Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.
‡9
1
|
|
919
|
|
|
‡a
globalupdateonthesusceptibilityofhumaninfluenzavirusestoneuraminidaseinhibitors2012
‡A
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.
‡9
1
|
|
919
|
|
|
‡a
globalupdateonthesusceptibilityofhumaninfluenzavirusestoneuraminidaseinhibitors2013
‡A
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.
‡9
1
|
|
919
|
|
|
‡a
globalupdateonthesusceptibilityofhumaninfluenzavirusestoneuraminidaseinhibitors2014
‡A
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
‡9
1
|
|
919
|
|
|
‡a
molecularcharacterizationofthehageneofinfluenzatypebviruses
‡A
Molecular characterization of the HA gene of influenza type B viruses
‡9
1
|
|
919
|
|
|
‡a
influenzaactivity2000
‡A
Influenza activity 2000/2001
‡9
1
|
|
919
|
|
|
‡a
influenzaah1n1pdm09resistanceandcrossdecreasedsusceptibilitytooseltamivirandzanamivirantiviraldrugs
‡A
Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
‡9
1
|
|
919
|
|
|
‡a
heterogeneousselectivepressureactingoninfluenzabvictoriaandyamagatalikehemagglutinins
‡A
Heterogeneous Selective Pressure Acting on Influenza B Victoria- and Yamagata-Like Hemagglutinins
‡9
1
|
|
919
|
|
|
‡a
globalupdateonthesusceptibilityofhumaninfluenzavirusestoneuraminidaseinhibitors2015
‡A
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
‡9
1
|
|
919
|
|
|
‡a
revisionofclinicalcasedefinitionsinfluenzalikeillnessandsevereacuterespiratoryinfection
‡A
Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection
‡9
1
|
|
919
|
|
|
‡a
reversegeneticsvaccineseedsforinfluenzaproofofconceptinthesourceofpb1asadeterminantfactorinvirusgrowthandantigenyield
‡A
Reverse genetics vaccine seeds for influenza: Proof of concept in the source of PB1 as a determinant factor in virus growth and antigen yield
‡9
1
|
|
919
|
|
|
‡a
populationgeneticsofifitm3inportugalandcentralafricarevealsapotentialmodifierofinfluenzaseverity
‡A
Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity
‡9
1
|
|
919
|
|
|
‡a
outbreakofacuterespiratoryinfectionamonginfantsinlisbonportugalcausedbyhumanadenovirusserotype3andanew73recombinantstrain
‡A
Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain
‡9
1
|
|
919
|
|
|
‡a
antibodyresponsetotheinfluenzavaccineinhealthcareworkers
‡A
Antibody response to the influenza vaccine in healthcare workers
‡9
1
|
|
919
|
|
|
‡a
bronchiolitiscausedbyrespiratorysyncytialvirusinanareaofportugalepidemiologyclinicalfeaturesandriskfactors
‡A
Bronchiolitis caused by respiratory syncytial virus in an area of portugal: epidemiology, clinical features, and risk factors
‡9
1
|
|
943
|
|
|
‡a
200x
‡A
2005
‡9
4
|
|
943
|
|
|
‡a
201x
‡A
2013
‡9
4
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
NUKAT|n 2016201202
|
|
996
|
|
|
‡2
PTBNP|1037394
|
|
996
|
|
|
‡2
BIBSYS|90264166
|
|
996
|
|
|
‡2
DNB|116306939
|
|
996
|
|
|
‡2
SUDOC|229593941
|
|
996
|
|
|
‡2
ISNI|0000000069103324
|
|
996
|
|
|
‡2
DNB|1204221650
|
|
996
|
|
|
‡2
LC|n 2020184018
|
|
996
|
|
|
‡2
ISNI|0000000030711680
|
|
996
|
|
|
‡2
PTBNP|5056
|
|
996
|
|
|
‡2
NTA|072571810
|
|
996
|
|
|
‡2
ISNI|0000000081112063
|
|
996
|
|
|
‡2
PTBNP|1673704
|
|
996
|
|
|
‡2
ISNI|0000000069787949
|
|
996
|
|
|
‡2
PTBNP|4914
|
|
996
|
|
|
‡2
PLWABN|9810644088505606
|
|
996
|
|
|
‡2
BNE|XX1548396
|
|
996
|
|
|
‡2
NDL|00431501
|
|
996
|
|
|
‡2
BLBNB|001576122
|
|
996
|
|
|
‡2
NII|DA19316214
|
|
996
|
|
|
‡2
LC|no2015063673
|
|
996
|
|
|
‡2
NSK|000774699
|
|
996
|
|
|
‡2
PTBNP|230258
|
|
996
|
|
|
‡2
PTBNP|175473
|
|
996
|
|
|
‡2
NUKAT|n 95300545
|
|
996
|
|
|
‡2
BNE|XX1155439
|
|
996
|
|
|
‡2
BLBNB|000532741
|
|
996
|
|
|
‡2
ISNI|0000000114665677
|
|
996
|
|
|
‡2
BLBNB|001514938
|
|
996
|
|
|
‡2
ISNI|0000000070133336
|
|
996
|
|
|
‡2
PLWABN|9810589001305606
|
|
996
|
|
|
‡2
ISNI|000000007976971X
|
|
996
|
|
|
‡2
PLWABN|9812692504505606
|
|
996
|
|
|
‡2
LC|n 87841593
|
|
996
|
|
|
‡2
BLBNB|000512725
|
|
996
|
|
|
‡2
PTBNP|5061
|
|
996
|
|
|
‡2
PTBNP|4886
|
|
996
|
|
|
‡2
BNE|XX894273
|
|
996
|
|
|
‡2
PTBNP|1506647
|
|
996
|
|
|
‡2
BNC|981058521701006706
|
|
996
|
|
|
‡2
BLBNB|000585891
|
|
996
|
|
|
‡2
SUDOC|243408722
|
|
996
|
|
|
‡2
LC|n 2019252181
|
|
996
|
|
|
‡2
PTBNP|911583
|
|
996
|
|
|
‡2
ISNI|0000000068917414
|
|
996
|
|
|
‡2
NSK|000098212
|
|
996
|
|
|
‡2
ISNI|0000000069521593
|
|
996
|
|
|
‡2
LIH|LNB:B_w_PM;=B_s_
|
|
996
|
|
|
‡2
PTBNP|280164
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
